Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Depreciation and Depletion (2020 - 2025)

Celularity (CELU) has disclosed Depreciation and Depletion for 5 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation and Depletion fell 4.67% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.9 million, a 8.36% decrease, with the full-year FY2024 number at $6.2 million, down 13.49% from a year prior.
  • Depreciation and Depletion was $1.4 million for Q3 2025 at Celularity, down from $1.5 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $2.1 million in Q4 2021 to a low of $1.4 million in Q1 2021.
  • A 4-year average of $1.6 million and a median of $1.5 million in 2024 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: grew 24.95% in 2022, then decreased 8.94% in 2025.
  • Celularity's Depreciation and Depletion stood at $2.1 million in 2021, then dropped by 15.14% to $1.7 million in 2022, then decreased by 13.94% to $1.5 million in 2024, then fell by 3.47% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Depreciation and Depletion are $1.4 million (Q3 2025), $1.5 million (Q2 2025), and $1.5 million (Q1 2025).